A Case Report of Three Guillain-Barré Syndrome During SARS-CoV-2 Pandemic: Promising Outcome in a Patient with History of Multiple Sclerosis
| Autor: | Amir ali Ghahremani, Amir Bigdeli, Davoud Salarbashi, Pouyan Shakouri, Sepideh Elyasi |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Journal of Pharmaceutical Care, Vol 10, Iss 3 (2022) |
| Druh dokumentu: | article |
| ISSN: | 2322-4630 2322-4509 54482593 |
| DOI: | 10.18502/jpc.v10i3.10800 |
| Popis: | Neurologic complications in patients with coronavirus disease 19 (COVID-19) are common particularly in hospitalized patients. Guillain–Barré syndrome (GBS) is a rare complication of COVID-19. Most patients with GBS and COVID-19 presented with progressive, ascending limb weakness evolving over one to four days. There are some reported cases of GBS, mostly in form of case reports or case series, and also a comprehensive review on this topic. However, none of these cases experienced multiple sclerosis (MS) as an underlying disease. So, in this manuscript we reported three cases of COVID-19 induced GBS; one of them with history of MS and promising outcome after receiving five session of plasmaphresis and corticosteroid therapy. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|